Tage Honore's Insider Trades & SAST Disclosures

Tage Honore's most recent trade in Vanda Pharmaceuticals Inc was a trade of 41,600 Common Stock done . Disclosure was reported to the exchange on June 4, 2026.

Share

Note

This is a custom search result for pattern Tage Honore.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2026	41,600	135,069 (0%)	0%		0	Common Stock
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Sale of securities on an exchange or to another person at price $ 8.03 per share.	23 Feb 2026	30,000	93,469 (0%)	0%	8.0	240,900	Common Stock
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2025	59,225	123,469 (0%)	0%		0	Common Stock
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2024	37,578	37,578	-		-	Stock Option (right to buy)
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 May 2024	20,529	64,244 (0%)	0%		0	Common Stock
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2023	33,960	33,960	-		-	Stock Option (right to buy)
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	08 Jun 2023	17,307	43,715 (0%)	0%		0	Common Stock
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2023	51,276	51,276	-		-	Stock Option (right to buy)
Vanda Pharma Inc Results Board Meeting	Tage Honore	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Mar 2023	26,408	26,408 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades